Filing Details

Accession Number:
0001209191-10-025474
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-05 13:00:00
Reporting Period:
2010-05-03
Filing Date:
2010-05-05
Accepted Time:
2010-05-05 17:01:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP Pharmaceutical Preparations (2834) 943267443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212673 A Richard Franco 1700 Perimeter Park Drive
Morrisville NC 27560
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-03 5,000 $40.22 49,244 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,500 Indirect By Spouse
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option to Buy Common Stock $17.63 2015-06-09 15,000 15,000 Direct
Common Stock Option to Buy Common Stock $18.87 2014-06-17 22,500 22,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-06-09 15,000 15,000 Direct
2014-06-17 22,500 22,500 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. Options are 100% vested.